Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection

Only limited data are available regarding the immunogenicity of the BNT162b2 mRNA vaccine in HIV-1(+) patients. Therefore, we investigated the humoral immune response after BNT162b2-mRNA vaccination or SARS-CoV-2 infection in HIV-1(+) patients on antiretroviral therapy compared to HIV-1-uninfected s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Katja G., Harrer, Ellen G., Tascilar, Koray, Kübel, Sabrina, El Kenz, Boutaina, Hartmann, Fabian, Simon, David, Schett, Georg, Nganou-Makamdop, Krystelle, Harrer, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952283/
https://www.ncbi.nlm.nih.gov/pubmed/35337058
http://dx.doi.org/10.3390/v14030651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952283/
https://www.ncbi.nlm.nih.gov/pubmed/35337058
http://dx.doi.org/10.3390/v14030651

Ejemplares similares